BCDA- Biocardia, Inc.

Name: Biocardia, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Altman Peter	280.8K	$301.8K	+6.0K
VP	Gillis Edward M	47.0K	$50.6K	-
CFO	McClung David	46.3K	$49.8K	-
Dir	Facteau Bill	15.7K	$16.9K	-
Dir	Moyes Jay M	15.6K	$16.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 12, 2025	Altman Peter48	President And CEO	Buy	400	$1.75	$700.40	+0.2%	-25.9%	-
Aug 11, 2025	Altman Peter48	President And CEO	Buy	1,700	$1.76	$2,988.60	+1.0%	-23.2%	-
Jun 30, 2025	McClung David	Chief Financial Officer	Buy	4,819	$2.08	$9,999.43	+11.2%	-28.2%	-
Jun 30, 2025	Altman Peter48	President And CEO	Buy	24,096	$2.08	$49,999.20	+17.0%	-28.2%	-
Jun 30, 2025	Blank Andrew Scott47	Director	Buy	72,289	$2.08	$149,999.68	+26.4%	-28.2%	-
Jun 30, 2025	Stertzer Simon H	Director	Buy	72,289	$2.08	$149,999.68	+60.1%	-28.2%	-
May 30, 2025	Altman Peter48	President And CEO	Buy	100	$2.21	$221.00	-	-9.3%	-
May 22, 2025	Altman Peter48	President And CEO	Buy	2,300	$2.02	$4,651.00	+0.8%	-3.7%	-
May 16, 2025	Altman Peter48	President And CEO	Buy	400	$2.57	$1,028.20	+0.1%	-22.5%	-
Apr 23, 2025	Stertzer Simon H	Director	Buy	104,986	$1.91	$199,998.33	+682.7%	+23.5%	-37.0%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC